Colina Yim

1.4k total citations
22 papers, 692 citations indexed

About

Colina Yim is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Colina Yim has authored 22 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 20 papers in Hepatology and 4 papers in Infectious Diseases. Recurrent topics in Colina Yim's work include Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (17 papers) and Liver Disease Diagnosis and Treatment (10 papers). Colina Yim is often cited by papers focused on Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (17 papers) and Liver Disease Diagnosis and Treatment (10 papers). Colina Yim collaborates with scholars based in Canada, Netherlands and United States. Colina Yim's co-authors include David Wong, Harry L.A. Janssen, Jordan J. Feld, Bettina E. Hansen, Morris Sherman, Jenny Heathcote, Barbara Paterson, Markus Backmund, E. Jenny Heathcote and Hemant Shah and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

Colina Yim

21 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Colina Yim Canada 12 585 567 69 31 24 22 692
Maryam Darvishian Canada 14 434 0.7× 432 0.8× 123 1.8× 13 0.4× 15 0.6× 34 562
Bożena Walewska‐Zielecka Poland 11 361 0.6× 380 0.7× 51 0.7× 13 0.4× 11 0.5× 41 520
Philip Vutien United States 15 438 0.7× 437 0.8× 41 0.6× 15 0.5× 39 1.6× 51 573
Hamish Innes United Kingdom 21 917 1.6× 867 1.5× 81 1.2× 25 0.8× 108 4.5× 57 1.1k
Salimur Rahman Bangladesh 13 381 0.7× 389 0.7× 45 0.7× 9 0.3× 14 0.6× 54 510
Karen F. Murray United States 15 678 1.2× 595 1.0× 48 0.7× 22 0.7× 11 0.5× 38 855
Mohamed Hassany Egypt 16 778 1.3× 775 1.4× 134 1.9× 8 0.3× 36 1.5× 95 1.0k
Rosemary C. Murphy United States 9 307 0.5× 286 0.5× 31 0.4× 10 0.3× 39 1.6× 14 564
Khozema B. Hussain United States 9 463 0.8× 480 0.8× 21 0.3× 23 0.7× 23 1.0× 11 609
Heitor Rosa Brazil 10 283 0.5× 258 0.5× 63 0.9× 17 0.5× 23 1.0× 18 405

Countries citing papers authored by Colina Yim

Since Specialization
Citations

This map shows the geographic impact of Colina Yim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colina Yim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colina Yim more than expected).

Fields of papers citing papers by Colina Yim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colina Yim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colina Yim. The network helps show where Colina Yim may publish in the future.

Co-authorship network of co-authors of Colina Yim

This figure shows the co-authorship network connecting the top 25 collaborators of Colina Yim. A scholar is included among the top collaborators of Colina Yim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colina Yim. Colina Yim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feld, Jordan J., André Boonstra, Sylvia M. Brakenhoff, et al.. (2024). Early HBcrAg and Anti‐HBc Levels Identify Patients at High Risk for Severe Flares After Nucleos(t)ide Analogue Cessation—A Pooled Analysis of Two Clinical Trials. Alimentary Pharmacology & Therapeutics. 61(3). 570–578. 2 indexed citations
2.
3.
Chi, Heng, Scott Fung, David Wong, et al.. (2022). Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B. Journal of Viral Hepatitis. 29(11). 986–993. 3 indexed citations
4.
Lee, Elizabeth, et al.. (2021). Impact of the COVID-19 pandemic on the experiences of hepatology nurses in Canada. Gastrointestinal Nursing. 19(Sup6). S27–S34. 1 indexed citations
5.
Mukhtar, Nizar A., Donna M. Evon, Colina Yim, et al.. (2020). Patient Knowledge, Beliefs and Barriers to Hepatitis B Care: Results of a Multicenter, Multiethnic Patient Survey. Digestive Diseases and Sciences. 66(2). 434–441. 12 indexed citations
6.
Evon, Donna M., Mandana Khalili, Robert J. Fontana, et al.. (2020). Patient‐reported outcomes in a large North American cohort living with chronic hepatitis B virus: a cross‐sectional analysis. Alimentary Pharmacology & Therapeutics. 51(4). 457–468. 10 indexed citations
7.
Brahmania, Mayur, Stephen V. Liu, Abdus S. Wahed, et al.. (2020). Alcohol, tobacco and coffee consumption and liver disease severity among individuals with Chronic Hepatitis B infection in North America. Annals of Hepatology. 19(4). 437–445. 8 indexed citations
8.
9.
Yim, Colina, Scott Fung, David Wong, et al.. (2019). Prevalence and predictors of complementary and alternative medicine modalities in patients with chronic hepatitis B. Liver International. 39(8). 1418–1427. 7 indexed citations
10.
Sharma, Suraj, Matthew Kowgier, Bettina E. Hansen, et al.. (2017). Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis. Journal of Hepatology. 68(1). 92–99. 147 indexed citations
11.
Abu‐Amara, Mahmoud, Orlando Cerocchi, Suraj Sharma, et al.. (2015). The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infection. Gut. 65(8). 1347–1358. 34 indexed citations
12.
Yim, Colina, et al.. (2009). Sociocultural Factors That Potentially Affect the Institution of Prevention and Treatment Strategies for Hepatitis B in Chinese Canadians. SHILAP Revista de lepidopterología. 23(1). 31–36. 59 indexed citations
13.
Paterson, Barbara, et al.. (2007). The depiction of stigmatization in research about hepatitis C. International Journal of Drug Policy. 18(5). 364–373. 84 indexed citations
14.
Sherman, Morris, Lawrence Cohen, Magdy Elkashab, et al.. (2006). Clinical Recommendations for the Use of Recombinant Human Erythropoietin in Patients with Hepatitis C Virus Being Treated with Ribavirin. SHILAP Revista de lepidopterología. 20(7). 479–485. 18 indexed citations
15.
Milkiewicz, Piotr, Colina Yim, Isabelle Pache, & Jenny Heathcote. (2005). Diffuse Skin Reaction in Patient with Hepatitis B, Treated with Two Different Formulations of Pegylated Interferon. SHILAP Revista de lepidopterología. 19(11). 677–678. 9 indexed citations
16.
Yim, Colina, et al.. (1999). Long-term follow-up of a randomized trial of interferon therapy for chronic hepatitis B in a predominantly homosexual male population. Journal of Hepatology. 30(4). 557–563. 15 indexed citations
17.
Yim, Colina, et al.. (1998). Durability of Serological Remission in Chronic Hepatitis C Treated With Interferon-Alpha-2B. The American Journal of Gastroenterology. 93(1). 39–43. 11 indexed citations
18.
Yim, Colina, et al.. (1996). The Interaction of Human Immunodeficiency Virus Infection and Hepatitis B Virus Infection in Infected Homosexual Men. Journal of Clinical Gastroenterology. 22(4). 299–304. 38 indexed citations
19.
Wong, David, Colina Yim, Erluo Chen, et al.. (1995). Interferon alfa treatment of chronic hepatitis B: Randomized trial in a predominantly homosexual male population. Gastroenterology. 108(1). 165–171. 67 indexed citations
20.
Heathcote, Jenny, et al.. (1989). Interferon-associated lymphocyte 2′,5′-oligoadenylate synthetase in acute and chronic viral hepatitis. Hepatology. 9(1). 105–109. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maryam Darvishian Breakdown of academic impact, for papers by Bożena Walewska‐Zielecka Breakdown of academic impact, for papers by Philip Vutien Breakdown of academic impact, for papers by Hamish Innes Breakdown of academic impact, for papers by Salimur Rahman Breakdown of academic impact, for papers by Karen F. Murray Breakdown of academic impact, for papers by Mohamed Hassany Breakdown of academic impact, for papers by Rosemary C. Murphy Breakdown of academic impact, for papers by Khozema B. Hussain Breakdown of academic impact, for papers by Heitor Rosa
Rankless by CCL
2026